NO20011829L - Oralt sertralinkonsentrat - Google Patents

Oralt sertralinkonsentrat

Info

Publication number: NO20011829L
Authority: NO; Norway
Prior art keywords: concentrate; oral sertraline; sertraline; oral; sertraline concentrate
Prior art date: 1998-10-13

Application number

NO20011829A

Other languages

English (en)

Norwegian (no)

Other versions

NO20011829D0 (no

Inventor

Nancy Jane Harper

Gautam Ramchandra Ranade

Willard Mckowan Welch

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-10-13

Filing date

2001-04-10

Publication date

2001-06-05

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22298286&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20011829(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-04-10 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2001-04-10 Publication of NO20011829D0 publication Critical patent/NO20011829D0/no

2001-06-05 Publication of NO20011829L publication Critical patent/NO20011829L/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Epidemiology (AREA)
Physical Education & Sports Medicine (AREA)
Psychiatry (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Vascular Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Addiction (AREA)
Urology & Nephrology (AREA)
Pain & Pain Management (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Nutrition Science (AREA)
Obesity (AREA)
Hematology (AREA)
Diabetes (AREA)
Oil, Petroleum & Natural Gas (AREA)
Child & Adolescent Psychology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

NO20011829A 1998-10-13 2001-04-10 Oralt sertralinkonsentrat NO20011829L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US10402498P	1998-10-13	1998-10-13
PCT/IB1999/001571 WO2000021521A2 (fr)	1998-10-13	1999-09-22	Concentre de sertraline par voie orale

Publications (2)

Publication Number	Publication Date
NO20011829D0 NO20011829D0 (no)	2001-04-10
NO20011829L true NO20011829L (no)	2001-06-05

Family

ID=22298286

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20011829A NO20011829L (no)	1998-10-13	2001-04-10	Oralt sertralinkonsentrat

Country Status (45)

Country	Link
EP (1)	EP1121107B1 (fr)
JP (1)	JP3792514B2 (fr)
KR (1)	KR100417200B1 (fr)
CN (1)	CN1184962C (fr)
AP (1)	AP2001002119A0 (fr)
AR (1)	AR014082A1 (fr)
AT (1)	ATE254453T1 (fr)
AU (1)	AU766202B2 (fr)
BG (1)	BG65085B1 (fr)
BR (1)	BR9914418A (fr)
CA (1)	CA2346335C (fr)
CO (1)	CO5150213A1 (fr)
CZ (1)	CZ20011286A3 (fr)
DE (1)	DE69912978T2 (fr)
DK (1)	DK1121107T3 (fr)
DZ (1)	DZ2913A1 (fr)
EA (1)	EA003990B1 (fr)
EE (1)	EE04868B1 (fr)
EG (1)	EG23818A (fr)
ES (1)	ES2209490T3 (fr)
GC (1)	GC0000175A (fr)
GE (1)	GEP20032969B (fr)
GT (1)	GT199900171A (fr)
HK (1)	HK1040199B (fr)
HR (1)	HRP20010263B1 (fr)
HU (1)	HUP0104470A3 (fr)
ID (1)	ID29845A (fr)
IS (1)	IS2239B (fr)
MA (1)	MA26698A1 (fr)
MY (1)	MY122477A (fr)
NO (1)	NO20011829L (fr)
NZ (1)	NZ510756A (fr)
OA (1)	OA11662A (fr)
PA (1)	PA8483301A1 (fr)
PE (1)	PE20001108A1 (fr)
PL (1)	PL348119A1 (fr)
PT (1)	PT1121107E (fr)
SK (1)	SK4582001A3 (fr)
TN (1)	TNSN99190A1 (fr)
TR (1)	TR200101090T2 (fr)
TW (1)	TWI228043B (fr)
UA (1)	UA72743C2 (fr)
WO (1)	WO2000021521A2 (fr)
YU (1)	YU26401A (fr)
ZA (1)	ZA200102900B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
UA75580C2 (uk)	1999-09-03	2006-05-15	Апбі Холдінгс, Ллк	Застосування дапоксетину або його фармацевтично прийнятної солі в лікарському засобі для лікування розладу статевої функції та промисловий виріб для його застосування
US20030086972A1 (en) *	2000-08-09	2003-05-08	Appel Leah E.	Hydrogel-driven drug dosage form
WO2004065348A1 (fr)	2003-01-23	2004-08-05	Pfizer Products Inc.	Sels pharmaceutiquement acceptables de sertraline et compositions pharmaceutiques correspondantes
EP1626950A4 (fr) *	2003-05-23	2007-05-23	Transform Pharmaceuticals Inc	Compositions de sertraline
WO2005034910A1 (fr) *	2003-10-08	2005-04-21	Ranbaxy Laboratories Limited	Compositions pharmaceutiques liquides de sertraline a administration orale
WO2007052152A2 (fr) *	2005-11-07	2007-05-10	Aurobindo Pharma Limited	Concentré oral d'un antidépresseur
EP2131827A2 (fr)	2007-03-09	2009-12-16	New York University	Procédés et compositions pour le traitement de la dysrythmie thalamocorticale
CN109908354A (zh) *	2017-12-12	2019-06-21	万特制药(海南)有限公司	盐酸舍曲林口服浓缩液及其制备工艺

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4536518A (en) *	1979-11-01	1985-08-20	Pfizer Inc.	Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
US4940731A (en) *	1989-08-30	1990-07-10	Pfizer Inc.	Method of treating premature ejaculation using sertraline
ATE96999T1 (de) *	1989-08-30	1993-11-15	Pfizer	Verwendung von sertralin zur behandlung von abhaengigkeiten von chemischen stoffen.
US5130338A (en) *	1989-08-30	1992-07-14	Pfizer Inc.	Method of treating chemical dependencies using sertraline
US4962128A (en) *	1989-11-02	1990-10-09	Pfizer Inc.	Method of treating anxiety-related disorders using sertraline
CA2143070C (fr) *	1994-02-22	2001-12-18	Pankaj Modi	Formulation pharmaceutique sous forme de suspension liquide administree par voie orale, pour degagement prolonge
US5597826A (en) *	1994-09-14	1997-01-28	Pfizer Inc.	Compositions containing sertraline and a 5-HT1D receptor agonist or antagonist
SE508372C2 (sv) *	1995-02-13	1998-09-28	Kjell Lindstroem	Metod och utrustning för tillförsel eller aspiration av substanser inom gastrointestinalkanalen, avsedd för mätning av farmakokinetiska och fysikalisk-kemiska parametrar
DK0768083T3 (da) *	1995-07-17	2003-06-23	Pfizer	Anvendelse af sertralin til at behandle patienter med post myocardisk infarkt
PL337807A1 (en) *	1997-07-01	2000-09-11	Pfizer Prod Inc	Sertralin dosage formulation in the form of a gelatine-encapsulated solution

1999
- 1999-09-22 EA EA200100285A patent/EA003990B1/ru not_active IP Right Cessation
- 1999-09-22 HR HR20010263A patent/HRP20010263B1/xx not_active IP Right Cessation
- 1999-09-22 PL PL99348119A patent/PL348119A1/xx not_active Application Discontinuation
- 1999-09-22 TR TR2001/01090T patent/TR200101090T2/xx unknown
- 1999-09-22 JP JP2000575497A patent/JP3792514B2/ja not_active Expired - Fee Related
- 1999-09-22 YU YU26401A patent/YU26401A/sh unknown
- 1999-09-22 SK SK458-2001A patent/SK4582001A3/sk unknown
- 1999-09-22 EP EP99943168A patent/EP1121107B1/fr not_active Expired - Lifetime
- 1999-09-22 AP APAP/P/2001/002119A patent/AP2001002119A0/en unknown
- 1999-09-22 ES ES99943168T patent/ES2209490T3/es not_active Expired - Lifetime
- 1999-09-22 BR BR9914418-2A patent/BR9914418A/pt not_active Application Discontinuation
- 1999-09-22 EE EEP200100221A patent/EE04868B1/xx not_active IP Right Cessation
- 1999-09-22 CA CA002346335A patent/CA2346335C/fr not_active Expired - Fee Related
- 1999-09-22 HK HK02101974.6A patent/HK1040199B/zh not_active IP Right Cessation
- 1999-09-22 GE GEAP19995852A patent/GEP20032969B/en unknown
- 1999-09-22 KR KR10-2001-7004559A patent/KR100417200B1/ko not_active Expired - Fee Related
- 1999-09-22 AT AT99943168T patent/ATE254453T1/de not_active IP Right Cessation
- 1999-09-22 HU HU0104470A patent/HUP0104470A3/hu unknown
- 1999-09-22 WO PCT/IB1999/001571 patent/WO2000021521A2/fr not_active Ceased
- 1999-09-22 AU AU56436/99A patent/AU766202B2/en not_active Ceased
- 1999-09-22 CN CNB998120871A patent/CN1184962C/zh not_active Expired - Fee Related
- 1999-09-22 UA UA2001042450A patent/UA72743C2/uk unknown
- 1999-09-22 OA OA1200100087A patent/OA11662A/en unknown
- 1999-09-22 PT PT99943168T patent/PT1121107E/pt unknown
- 1999-09-22 CZ CZ20011286A patent/CZ20011286A3/cs unknown
- 1999-09-22 NZ NZ510756A patent/NZ510756A/en unknown
- 1999-09-22 DK DK99943168T patent/DK1121107T3/da active
- 1999-09-22 DE DE69912978T patent/DE69912978T2/de not_active Expired - Fee Related
- 1999-09-22 ID IDW20010824A patent/ID29845A/id unknown
- 1999-09-28 PA PA19998483301A patent/PA8483301A1/es unknown
- 1999-10-05 GT GT199900171A patent/GT199900171A/es unknown
- 1999-10-06 TW TW088117244A patent/TWI228043B/zh not_active IP Right Cessation
- 1999-10-08 AR ARP990105116A patent/AR014082A1/es unknown
- 1999-10-09 GC GCP1999314 patent/GC0000175A/en active
- 1999-10-11 PE PE1999001025A patent/PE20001108A1/es not_active Application Discontinuation
- 1999-10-11 MY MYPI99004384A patent/MY122477A/en unknown
- 1999-10-12 DZ DZ990213A patent/DZ2913A1/fr active
- 1999-10-12 MA MA25814A patent/MA26698A1/fr unknown
- 1999-10-12 TN TNTNSN99190A patent/TNSN99190A1/fr unknown
- 1999-10-12 EG EG127599A patent/EG23818A/xx active
- 1999-10-13 CO CO99065089A patent/CO5150213A1/es unknown
2001
- 2001-03-23 IS IS5906A patent/IS2239B/is unknown
- 2001-04-09 ZA ZA200102900A patent/ZA200102900B/xx unknown
- 2001-04-10 NO NO20011829A patent/NO20011829L/no not_active Application Discontinuation
- 2001-04-10 BG BG105434A patent/BG65085B1/bg unknown

Also Published As

Publication number	Publication date
BR9914418A (pt)	2001-06-26
CN1323202A (zh)	2001-11-21
AU766202B2 (en)	2003-10-09
AU5643699A (en)	2000-05-01
WO2000021521A2 (fr)	2000-04-20
WO2000021521A3 (fr)	2000-07-20
IS2239B (is)	2007-05-15
KR100417200B1 (ko)	2004-02-05
TNSN99190A1 (fr)	2005-11-10
IS5906A (is)	2001-03-23
EE04868B1 (et)	2007-08-15
TWI228043B (en)	2005-02-21
YU26401A (sh)	2005-07-19
DZ2913A1 (fr)	2004-03-01
HUP0104470A2 (en)	2002-08-28
EP1121107B1 (fr)	2003-11-19
DE69912978D1 (de)	2003-12-24
PT1121107E (pt)	2004-02-27
BG65085B1 (bg)	2007-02-28
CA2346335C (fr)	2006-04-18
ATE254453T1 (de)	2003-12-15
BG105434A (en)	2001-12-29
CO5150213A1 (es)	2002-04-29
PL348119A1 (en)	2002-05-06
ES2209490T3 (es)	2004-06-16
MY122477A (en)	2006-04-29
GEP20032969B (en)	2003-05-27
EA200100285A1 (ru)	2001-10-22
HK1040199A1 (en)	2002-05-31
PE20001108A1 (es)	2000-10-26
AP2001002119A0 (en)	2001-03-22
EP1121107A2 (fr)	2001-08-08
UA72743C2 (en)	2005-04-15
HK1040199B (zh)	2005-05-27
HRP20010263A2 (en)	2002-06-30
EG23818A (en)	2007-09-19
HRP20010263B1 (en)	2005-04-30
DK1121107T3 (da)	2004-02-23
ZA200102900B (en)	2002-05-29
CA2346335A1 (fr)	2000-04-20
JP2002527385A (ja)	2002-08-27
DE69912978T2 (de)	2004-04-22
HUP0104470A3 (en)	2003-12-29
GC0000175A (en)	2006-03-29
NO20011829D0 (no)	2001-04-10
MA26698A1 (fr)	2004-12-20
NZ510756A (en)	2003-05-30
TR200101090T2 (tr)	2001-12-21
ID29845A (id)	2001-10-18
AR014082A1 (es)	2001-01-31
KR20010080096A (ko)	2001-08-22
CN1184962C (zh)	2005-01-19
JP3792514B2 (ja)	2006-07-05
EE200100221A (et)	2002-08-15
GT199900171A (es)	2001-03-28
CZ20011286A3 (cs)	2001-09-12
EA003990B1 (ru)	2003-12-25
SK4582001A3 (en)	2002-02-05
OA11662A (en)	2004-12-08
PA8483301A1 (es)	2000-09-29

Publication	Publication Date	Title
ID26936A (id)	2001-02-22	Komposisi herbisida konsentrat
ID26720A (id)	2001-02-01	Komposisi oral
DE69912286D1 (de)	2003-11-27	Zahnbürste
DE69827672D1 (de)	2004-12-23	Teleskopartiges intraorales kraftelement
DE69934002D1 (de)	2006-12-28	Zahnbürste
IS5555A (is)	2000-06-30	Selekoxib lyfjablöndur
ID30031A (id)	2001-11-01	Formulasi-formulasi agrokimia
ID23546A (id)	2000-05-04	Formulasi-formulasi ziprasidon
DE69934771D1 (de)	2007-02-22	Zahnbürste
NO20004240D0 (no)	2000-08-24	Formuleringer
ATE224703T1 (de)	2002-10-15	Brauseformulierungen
PT1130966E (pt)	2005-04-29	Formulacoes antiparasitarias
DE60007530D1 (de)	2004-02-05	Oral wirksame androgene
DE69920345D1 (de)	2004-10-28	Fräsmeissel
ATE217021T1 (de)	2002-05-15	Präparationsmittel
DK1121107T3 (da)	2004-02-23	Oralt sertralin-koncentrat
FR2782671B3 (fr)	2000-07-21	Livre
IS5260A (is)	1999-11-19	Uppleystar sertralín samsetningar
FI980856A0 (fi)	1998-04-17	Andningsskydd utrustad med en identifierare
IS5877A (is)	2001-03-05	Ný efnablanda
DE59901177D1 (de)	2002-05-16	Zahnbürste
ATE254866T1 (de)	2003-12-15	Zahnbürste
IS5879A (is)	2001-03-07	Ný efnablanda
NO995788D0 (no)	1999-11-25	Arbeidsbord
SI1121107T1 (en)	2004-04-30	Sertraline oral concentrate

Legal Events

Date	Code	Title	Description
2009-04-27	FC2A	Withdrawal, rejection or dismissal of laid open patent application